1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Issue 10374 (4th February 2023) Authors: Swen, Jesse J; van der Wouden, Cathelijne H; Manson, Lisanne EN; Abdullah-Koolmees, Heshu; Blagec, Kathrin; Blagus, Tanja; Böhringer, Stefan; Cambon-Thomsen, Anne; Cecchin, Erika; Cheung, Ka-Chun; Deneer, Vera HM; Dupui, Mathilde; Ingelman-Sundberg, Magnus; Jonsson, Siv; Joefield-Roka, Candace; J... Journal: Lancet Issue: Volume 401:Issue 10374(2023) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-TNF therapeutics for the treatment of sarcoidosis. (October 2014) Authors: Crommelin, Heleen A; Vorselaars, Adriane DM; van Moorsel, Coline HM; Korenromp, Ingrid HE; Deneer, Vera HM; Grutters, Jan C Journal: Immunotherapy Issue: Volume 6:Number 10(2014:Oct.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-TNF therapeutics for the treatment of sarcoidosis. (October 2014) Authors: Crommelin, Heleen A; Vorselaars, Adriane DM; van Moorsel, Coline HM; Korenromp, Ingrid HE; Deneer, Vera HM; Grutters, Jan C Journal: Immunotherapy Issue: Volume 6:Number 10(2014:Oct.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel. (February 2011) Authors: Peters, Bas JM; Harmsze, Ankie M; ten Berg, Jurriëën M; Maitland-van der Zee, Anke-Hilse; Tjoeng, Mathieu M; de Boer, Anthonius; Deneer, Vera HM Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel. (February 2011) Authors: Peters, Bas JM; Harmsze, Ankie M; ten Berg, Jurriëën M; Maitland-van der Zee, Anke-Hilse; Tjoeng, Mathieu M; de Boer, Anthonius; Deneer, Vera HM Journal: Pharmacogenomics Issue: Volume 12:Number 2(2011) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy. (May 2018) Authors: Bergmeijer, Thomas O; Vos, Gerrit JA; Claassens, Daniël MF; Janssen, Paul WA; Harms, Remko; der Heide, Richard van; Asselbergs, Folkert W; ten Berg, Jurriën M; Deneer, Vera HM Journal: Pharmacogenomics Issue: Volume 19:Number 7(2018) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis?. (July 2015) Authors: Crommelin, Heleen A; Vorselaars, Adriane DM; van Moorsel, Coline HM; Korenromp, Ingrid HE; Deneer, Vera HM; Grutters, Jan C Journal: Immunotherapy Issue: Volume 7:Number 6(2015:Jun.) Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacogenomics of oral antiplatelet drugs. (March 2014) Authors: Yasmina, Alfi; de Boer, Anthonius; Klungel, Olaf H; Deneer, Vera HM Journal: Pharmacogenomics Issue: Volume 15:Number 4(2014) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacogenomics of oral antiplatelet drugs. (March 2014) Authors: Yasmina, Alfi; de Boer, Anthonius; Klungel, Olaf H; Deneer, Vera HM Journal: Pharmacogenomics Issue: Volume 15:Number 4(2014) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗